Please refer the attached intimation.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transchem Limited has published its un-audited financial results for the quarter and nine months ended December 31, 2025 in Financial Express and Mumbai Lakshadeep newspapers, as required under SEBI Listing Regulations. For Q3 FY26, total income stood at ₹224.78 lakhs (down from ₹239.96 lakhs in Q3 FY25), with net profit after tax of ₹52.94 lakhs (down sharply from ₹138.94 lakhs in Q3 FY25). Basic EPS for the quarter was ₹0.43 versus ₹1.13 a year ago. For the nine-month period (Apr-Dec 2025), total income was ₹555.98 lakhs versus ₹717.68 lakhs last year, while net profit after tax was ₹220.19 lakhs versus ₹449.61 lakhs — roughly halving year-on-year. The company also noted that shareholders approved the issuance of up to 6.15 crore warrants on a preferential basis at ₹75 per warrant at an EGM held on December 20, 2025, with BSE in-principle approval still pending. No warrants had been allotted as of December 31, 2025, so there is no impact on current results.
Both quarterly and year-to-date earnings have declined significantly compared to the previous year, with net profit nearly halving in the nine-month period. This is largely a procedural filing of already-disclosed results, but the underlying performance weakness is a negative signal for shareholders. The pending preferential warrant issue at ₹75 per share is a capital structure event to watch.